Drug-Food and Drug-Supplement Interactions

Drug-food and drug-supplement interactions occur when a food, beverage, dietary supplement, or herbal product changes the effect of a medicine — either by altering how the body absorbs or metabolises the drug (a pharmacokinetic effect) or by acting on the same physiological system as the drug (a pharmacodynamic effect). Because foods and supplements are often not regarded as medicines, these interactions can go unrecognised.

Definition

A drug-food or drug-supplement interaction is an interaction in which a food, beverage, dietary supplement, or herbal product alters the absorption, metabolism, or excretion of a drug, or its physiological effect, changing the drug's clinical outcome.

Scope

The topic covers interactions between drugs and dietary constituents, beverages, and over-the-counter herbal or nutritional supplements. It includes both pharmacokinetic mechanisms (such as inhibition or induction of metabolising enzymes and transporters, or binding in the gut) and pharmacodynamic mechanisms (such as a dietary constituent opposing a drug's action). It is reference material on mechanism and recognition, not dietary, dosing, or prescribing instruction.

Core questions

• Is the dietary or supplement constituent altering the drug's concentration or its effect?
• Does the interaction involve a metabolising enzyme, a transporter, gut binding, or a shared physiological system?
• Why are interactions involving foods and supplements often under-reported?

Key concepts

• Pharmacokinetic versus pharmacodynamic food interactions
• Grapefruit juice and intestinal CYP3A4 inhibition
• Herbal enzyme induction (e.g., St John's wort)
• Dietary vitamin K and vitamin K antagonist anticoagulants
• Chelation and binding in the gut
• Under-reporting of supplement use

Mechanisms

Foods and supplements can act through the same routes as drug-drug interactions. Some inhibit metabolising enzymes: grapefruit constituents inhibit intestinal cytochrome P450 3A4, reducing first-pass metabolism and raising the absorbed amount of certain oral drugs (bailey-2012; fuhr-1998). Some induce enzymes and transporters: St John's wort induces CYP3A4 and P-glycoprotein, lowering the exposure of affected drugs (durr-2000). Others bind drugs in the gut and reduce absorption, for example through chelation by certain minerals. Pharmacodynamic food interactions act on a shared system rather than on concentration — the classic example being dietary vitamin K, which opposes the action of vitamin K antagonist anticoagulants (violi-2016).

Clinical relevance

Food and supplement interactions are an important and easily missed contributor to medication safety, partly because patients may not mention foods or non-prescription products during medication review (bailey-2012; durr-2000). This entry explains the mechanisms and why such interactions are under-recognised, as reference and appraisal material; it is not dietary advice, dosing guidance, or a basis for individual treatment decisions, which require current professional sources.

Evidence & guidelines

Evidence ranges from mechanistic and pharmacokinetic studies of specific food-drug pairs (such as grapefruit juice) to systematic review of contested interactions (such as dietary vitamin K and anticoagulation, where the practical magnitude has been re-examined) (fuhr-1998; violi-2016). Specific recommendations about diet, supplement use, and medication timing belong to current clinical guidance and individual assessment, outside the scope of this reference entry.

History

The grapefruit juice interaction, recognised in the late twentieth century as an unexpected and reproducible enhancement of certain drugs' absorption, drew wide attention to food as a source of clinically meaningful drug interactions and prompted systematic study of its mechanism and extent (fuhr-1998; bailey-2012). The subsequent recognition that popular herbal products such as St John's wort can potently induce drug-metabolising enzymes extended the field to dietary supplements (durr-2000).

Debates

How clinically significant is the dietary vitamin K interaction with vitamin K antagonists?

Although dietary vitamin K plausibly opposes vitamin K antagonist anticoagulants, systematic review has questioned how large and consistent the practical effect is, leaving the magnitude and management of the interaction a matter of ongoing evaluation.

Seminal works

• bailey-2012
• fuhr-1998
• violi-2016

Frequently asked questions

Why should some medicines not be taken with grapefruit juice?

Grapefruit constituents inhibit the cytochrome P450 3A4 enzyme in the intestinal wall that normally breaks down certain drugs before they are absorbed. With less breakdown, more of the drug enters the bloodstream, which can amplify its effect for some medicines.

Are herbal supplements free of interaction risk because they are natural?

No. Being natural does not mean being inert. Some herbal products, such as St John's wort, strongly induce drug-metabolising enzymes and transporters and can substantially reduce the effectiveness of co-administered medicines.